IDEXX Laboratories IDXX
CEO: Jay Mazelsky · Diagnostics · 11,300 employees
Compensation Breakdown
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $2.1M | — | $3.2M | $1.0M | $979K | $198K | $7.5M |
| 2024 | $2.0M | $433K | $3.2M | $1.6M | $1.3M | $32K | $8.5M |
| 2023 | $2.0M | — | $2.7M | $967K | $431K | $182K | $6.6M |
| 2022 | $1.9M | — | $3.4M | $814K | $613K | $129K | $6.9M |
All compensation data is sourced from SEC DEF 14A proxy filings submitted to EDGAR. The Economic Policy Institute's CEO pay analysis provides additional context on executive compensation trends across industries.
Named Executive Officers
Frequently Asked Questions
Jay Mazelsky, CEO of IDEXX Laboratories (IDXX), earns $7.5M in total compensation. This includes base salary, stock awards, option awards, and other incentives as reported in the company's most recent DEF 14A proxy statement.
IDEXX Laboratories has a Pay-for-Performance Score of C (56/100). The company's 3-year total shareholder return is +26.6%, and the say-on-pay shareholder vote passed with 65.7% approval.
The CEO-to-median-worker pay ratio at IDEXX Laboratories is 72:1. The median worker at IDEXX Laboratories earns $103K per year, while CEO Jay Mazelsky earns $7.5M in total compensation.
IDEXX Laboratories employs approximately 11,300 people. The company operates in the Diagnostics industry within the Healthcare sector, generating $3.9B in annual revenue.